Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole A Long

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
Scientific Reports|September 28, 2024
A human-serum-free medium can induce more infectious P. falciparum gametocytes than a conventional human-serum-containing mediumKazutoyo Miura, Bingbing Deng, Ragavan Varadharajan Suresh, et al.
Malaria Journal|September 4, 2019
Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mLGeneviève M Labbé, Kazutoyo Miura, Sarah E Silk, et al.
Infection and Immunity|September 5, 2013
RALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigenDaisuke Ito, Tomoyuki Hasegawa, Kazutoyo Miura, et al.
Vaccine|May 5, 2009
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsRuth D Ellis, Gregory E D Mullen, Mark Pierce, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2014
Multiple pathways for Plasmodium ookinete invasion of the mosquito midgutJoel Vega-Rodríguez, Anil K Ghosh, Stefan M Kanzok, et al.
Antimicrobial Agents and Chemotherapy|March 1, 2023
Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei OoklucJuliana Calit, Jessica E Araújo, Bingbing Deng, et al.
The Journal of Infectious Diseases|June 12, 2025
Priming or Boosting P. falciparum Transmission Blocking Responses with Recombinant Vaccines or Gametocyte ExtractYiting Song, Bingbing Deng, Carole A Long, et al.
Plos One|June 23, 2011
Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assayKazutoyo Miura, Suwani Perera, Sarah Brockley, et al.
Vaccine|August 22, 2018
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adultsJessica A Chichester, Brian J Green, R Mark Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccinationKazutoyo Miura, Hong Zhou, Samuel E Moretz, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Scientific Reports|September 28, 2024
A human-serum-free medium can induce more infectious P. falciparum gametocytes than a conventional human-serum-containing mediumKazutoyo Miura, Bingbing Deng, Ragavan Varadharajan Suresh, et al.
Malaria Journal|September 4, 2019
Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mLGeneviève M Labbé, Kazutoyo Miura, Sarah E Silk, et al.
Infection and Immunity|September 5, 2013
RALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigenDaisuke Ito, Tomoyuki Hasegawa, Kazutoyo Miura, et al.
Vaccine|May 5, 2009
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsRuth D Ellis, Gregory E D Mullen, Mark Pierce, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2014
Multiple pathways for Plasmodium ookinete invasion of the mosquito midgutJoel Vega-Rodríguez, Anil K Ghosh, Stefan M Kanzok, et al.
Antimicrobial Agents and Chemotherapy|March 1, 2023
Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei OoklucJuliana Calit, Jessica E Araújo, Bingbing Deng, et al.
The Journal of Infectious Diseases|June 12, 2025
Priming or Boosting P. falciparum Transmission Blocking Responses with Recombinant Vaccines or Gametocyte ExtractYiting Song, Bingbing Deng, Carole A Long, et al.
Plos One|June 23, 2011
Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assayKazutoyo Miura, Suwani Perera, Sarah Brockley, et al.
Vaccine|August 22, 2018
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adultsJessica A Chichester, Brian J Green, R Mark Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccinationKazutoyo Miura, Hong Zhou, Samuel E Moretz, et al.
Pageof 21